ANI Pharmaceuticals (ANIP) announced that following final approval from the U.S. FDA for its Abbreviated New Drug Application, the company ...

ANI Pharmaceuticals (NASDAQ:ANIP) announced that following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06% ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration ...

TATA AIG General Insurance Company Limited and Dun & Bradstreet India released the Horizon Watch Emerging Risk Report, a collaborative research effort identifying and analysing emerging risks that ...

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- (ANI or the Company) (Nasdaq: ANIP) today announced that following final ...

Gujarat welcomed Spanish Prime Minister Pedro Sanchez Perez-Castejon on Thursday His visit for the inauguration of the Tata-Airbus manufacturing facility in ...

Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its price objective lifted by equities researchers at Truist Financial from $60.00 to $62.00 in a report released on Tuesday, Benzinga reports.

Truist raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $62 from $60 and keeps a Hold rating on the shares as ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Alnylam Pharmaceuticals (ALNY) been one of those stocks this year? Let's take a ...

India has emerged as a global leader in pharmaceuticals, being the third-largest producer and a key supplier of generic medicines, said Union Health Secretary P ...

Piper Sandler started coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The firm issued an overweight ...